These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1363937)

  • 1. [Main drug interactions at a hospital emergency department. Analysis of 100 cases].
    Martí A; de Kolster CC; Kolster J
    G E N; 1992; 46(1):4-9. PubMed ID: 1363937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Report about drug interactions in a hospital emergency department].
    Kolster J; Martí A; Castro de Kolster C; Fonseca A
    G E N; 1993; 47(4):204-8. PubMed ID: 8050696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug interactions with H2-receptor antagonists in intensive care unit patients.
    Monaghan MS; Falls L; Olsen KM
    Hosp Pharm; 1993 Apr; 28(4):296-7, 300-1, 305 passim. PubMed ID: 10136586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients. A randomized study comparing the efficacy of sucralfate, cimetidine, and antacids.
    Cannon LA; Heiselman D; Gardner W; Jones J
    Arch Intern Med; 1987 Dec; 147(12):2101-6. PubMed ID: 3500684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
    Segal R; Russell WL; Oh T; Ben-Joseph R
    Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine use and risk of prostate and breast cancer.
    Rossing MA; Scholes D; Cushing-Haugen KL; Voigt LF
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):319-23. PubMed ID: 10750671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant gastric ulcer: its natural history and outcome in the H2RA era.
    Raju GS; Bardhan KD; Royston C; Beresford J
    Am J Gastroenterol; 1999 Dec; 94(12):3478-86. PubMed ID: 10606307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer.
    Coogan PF; Zhang Y; Palmer JR; Strom BL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1012-5. PubMed ID: 15824181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
    Koren G; Zemlickis DM
    Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions: theory versus practice.
    Griffin JW; May JR; DiPiro JT
    Am J Med; 1984 Nov; 77(5B):85-9. PubMed ID: 6507453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions of H2 antagonists and non-depolarizing muscle relaxants].
    Tryba M; Wruck G
    Anaesthesist; 1989 May; 38(5):251-4. PubMed ID: 2567580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic.
    Hastings SN; Sloane RJ; Goldberg KC; Oddone EZ; Schmader KE
    J Am Geriatr Soc; 2007 Sep; 55(9):1339-48. PubMed ID: 17767675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department.
    Hohl CM; Dankoff J; Colacone A; Afilalo M
    Ann Emerg Med; 2001 Dec; 38(6):666-71. PubMed ID: 11719747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted practitioner-response system for studying the use of cimetidine.
    Schwartz JI; Kennedy TJ
    Am J Hosp Pharm; 1982 Jul; 39(7):1198-201. PubMed ID: 7114066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
    Dettmer RM; Riley TH; Byfield F; Green PH
    Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.